Published in BMC Biochem on December 01, 2005
The depletion of skeletal muscle satellite cells with age is concomitant with reduced capacity of single progenitors to produce reserve progeny. Dev Biol (2010) 1.34
DUX4c is up-regulated in FSHD. It induces the MYF5 protein and human myoblast proliferation. PLoS One (2009) 1.12
Regulation of neurogenin stability by ubiquitin-mediated proteolysis. Biochem J (2007) 1.05
A distinct profile of myogenic regulatory factor detection within Pax7+ cells at S phase supports a unique role of Myf5 during posthatch chicken myogenesis. Dev Dyn (2009) 1.02
Functional characterization of Anaphase Promoting Complex/Cyclosome (APC/C) E3 ubiquitin ligases in tumorigenesis. Biochim Biophys Acta (2014) 1.00
Regulation of death-associated protein kinase. Stabilization by HSP90 heterocomplexes. J Biol Chem (2007) 0.95
Phosphorylation-dependent degradation of MEF2C contributes to regulate G2/M transition. Cell Cycle (2015) 0.86
Overexpression of annexin A2 is associated with abnormal ubiquitination in breast cancer. Genomics Proteomics Bioinformatics (2012) 0.82
Protein 4.1R Influences Myogenin Protein Stability and Skeletal Muscle Differentiation. J Biol Chem (2016) 0.75
The ubiquitin system. Annu Rev Biochem (1998) 43.36
Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell (1987) 22.17
Universal control mechanism regulating onset of M-phase. Nature (1990) 19.11
Cyclin is degraded by the ubiquitin pathway. Nature (1991) 17.93
Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem (1998) 13.93
Cyclin synthesis drives the early embryonic cell cycle. Nature (1989) 9.73
SCF and Cullin/Ring H2-based ubiquitin ligases. Annu Rev Cell Dev Biol (1999) 9.54
The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem (1991) 8.92
A 20S complex containing CDC27 and CDC16 catalyzes the mitosis-specific conjugation of ubiquitin to cyclin B. Cell (1995) 8.34
Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. Annu Rev Cell Dev Biol (1998) 7.31
Multisite phosphorylation of a CDK inhibitor sets a threshold for the onset of DNA replication. Nature (2001) 7.31
Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science (1995) 7.25
MyoD or Myf-5 is required for the formation of skeletal muscle. Cell (1993) 7.14
Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. Eur J Biochem (1997) 6.99
Cyclin activation of p34cdc2. Cell (1990) 6.87
Anaphase is initiated by proteolysis rather than by the inactivation of maturation-promoting factor. Cell (1993) 6.84
The cyclosome, a large complex containing cyclin-selective ubiquitin ligase activity, targets cyclins for destruction at the end of mitosis. Mol Biol Cell (1995) 6.23
Cyclosporin A inhibits T-cell growth factor gene expression at the level of mRNA transcription. Proc Natl Acad Sci U S A (1984) 4.90
Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase. Science (1995) 4.06
Basic Medical Research Award. The ubiquitin system. Nat Med (2000) 4.03
Mitotic regulation of the APC activator proteins CDC20 and CDH1. Mol Biol Cell (2000) 4.01
Anaphase-promoting complex/cyclosome-dependent proteolysis of human cyclin A starts at the beginning of mitosis and is not subject to the spindle assembly checkpoint. J Cell Biol (2001) 3.86
Prophase destruction of Emi1 by the SCF(betaTrCP/Slimb) ubiquitin ligase activates the anaphase promoting complex to allow progression beyond prometaphase. Dev Cell (2003) 3.53
Fizzy is required for activation of the APC/cyclosome in Xenopus egg extracts. EMBO J (1998) 3.02
Mrf4 determines skeletal muscle identity in Myf5:Myod double-mutant mice. Nature (2004) 3.00
Mutagenic analysis of the destruction signal of mitotic cyclins and structural characterization of ubiquitinated intermediates. Mol Biol Cell (1996) 2.99
Indirubins inhibit glycogen synthase kinase-3 beta and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors? J Biol Chem (2001) 2.79
Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases. Nat Cell Biol (1999) 2.78
Inhibition of cyclin-dependent kinases by purine analogues: crystal structure of human cdk2 complexed with roscovitine. Eur J Biochem (1997) 2.65
Ratchets and clocks: the cell cycle, ubiquitylation and protein turnover. Nat Rev Mol Cell Biol (2003) 2.64
MEK inhibitors: the chemistry and biological activity of U0126, its analogs, and cyclization products. Bioorg Med Chem Lett (1998) 2.61
Early expression of the myogenic regulatory gene, myf-5, in precursor cells of skeletal muscle in the mouse embryo. Development (1991) 2.60
Skeletal muscle formation in vertebrates. Curr Opin Genet Dev (2001) 2.59
The muscle regulatory factors MyoD and myf-5 undergo distinct cell cycle-specific expression in muscle cells. J Cell Biol (1998) 2.50
Cell heterogeneity upon myogenic differentiation: down-regulation of MyoD and Myf-5 generates 'reserve cells'. J Cell Sci (1998) 2.43
Regulation of muscle regulatory factors by DNA-binding, interacting proteins, and post-transcriptional modifications. J Cell Physiol (2000) 2.33
Skeletal muscle hypertrophy is mediated by a Ca2+-dependent calcineurin signalling pathway. Nature (1999) 2.24
APC/C and SCF: controlling each other and the cell cycle. Curr Biol (2004) 2.14
Phosphorylation of the cyclosome is required for its stimulation by Fizzy/cdc20. Biochem Biophys Res Commun (1999) 1.93
Crosstalk between cell cycle regulators and the myogenic factor MyoD in skeletal myoblasts. Cell Mol Life Sci (2001) 1.89
Roscovitine and other purines as kinase inhibitors. From starfish oocytes to clinical trials. Acc Chem Res (2003) 1.88
Under arrest: cytostatic factor (CSF)-mediated metaphase arrest in vertebrate eggs. Genes Dev (2003) 1.80
Phosphorylation of nuclear MyoD is required for its rapid degradation. Mol Cell Biol (1998) 1.61
Multisite phosphorylation and the countdown to S phase. Cell (2001) 1.59
Xenopus polo-like kinase Plx1 regulates XErp1, a novel inhibitor of APC/C activity. Genes Dev (2005) 1.57
Phosphorylation and activation of the Xenopus Cdc25 phosphatase in the absence of Cdc2 and Cdk2 kinase activity. Mol Biol Cell (1995) 1.50
APC/Fizzy-Related targets Aurora-A kinase for proteolysis. EMBO Rep (2002) 1.45
Cell cycle-regulated expression of the muscle determination factor Myf5 in proliferating myoblasts. J Cell Biol (1998) 1.43
Degradation of myogenic transcription factor MyoD by the ubiquitin pathway in vivo and in vitro: regulation by specific DNA binding. Mol Cell Biol (1998) 1.41
Direct inhibition of G(1) cdk kinase activity by MyoD promotes myoblast cell cycle withdrawal and terminal differentiation. EMBO J (1999) 1.33
Developmental patterns in the expression of Myf5, MyoD, myogenin, and MRF4 during myogenesis. New Biol (1991) 1.32
cdk1- and cdk2-mediated phosphorylation of MyoD Ser200 in growing C2 myoblasts: role in modulating MyoD half-life and myogenic activity. Mol Cell Biol (1999) 1.24
Myf5, MyoD, myogenin and MRF4 myogenic derivatives of the embryonic mesenchymal cell line C3H10T1/2 exhibit the same adult muscle phenotype. Differentiation (1994) 1.20
Xkid is degraded in a D-box, KEN-box, and A-box-independent pathway. Mol Cell Biol (2003) 1.16
Cyclin B/cdc2 induces c-Mos stability by direct phosphorylation in Xenopus oocytes. Mol Biol Cell (2001) 1.14
E12 and E47 modulate cellular localization and proteasome-mediated degradation of MyoD and Id1. Oncogene (2005) 1.10
Constitutive instability of muscle regulatory factor Myf5 is distinct from its mitosis-specific disappearance, which requires a D-box-like motif overlapping the basic domain. Mol Cell Biol (2000) 1.06
Cyclin E-cdk2 phosphorylation promotes late G1-phase degradation of MyoD in muscle cells. Exp Cell Res (2000) 1.04
Mutant MyoD lacking Cdc2 phosphorylation sites delays M-phase entry. Mol Cell Biol (2004) 0.98
The bisindolylmaleimide GF 109203X, a selective inhibitor of protein kinase C, does not inhibit the potentiating effect of phorbol ester on ethanol-induced phospholipase C-mediated hydrolysis of phosphatidylethanolamine. Biochim Biophys Acta (1995) 0.96
Differential effect of cyclosporin A on activation signaling in human T cell lines. J Clin Invest (1986) 0.92
The polo-like kinase Plx1 prevents premature inactivation of the APC(Fizzy)-dependent pathway in the early Xenopus cell cycle. Oncogene (2000) 0.90
Ca2+ is involved through type II calmodulin-dependent protein kinase in cyclin degradation and exit from metaphase. Biochim Biophys Acta (1994) 0.89
Biosynthesis of staurosporine, 1. 1H- and 13C-NMR assignments. J Nat Prod (1989) 0.86
Induction by staurosporine of hepatocyte growth factor production in human skin fibroblasts independent of protein kinase inhibition. Biochem Pharmacol (2003) 0.78
Cell density-dependent induction of endogenous myogenin (myf4) gene expression by Myf5. Dev Biol (2001) 0.77
Active cyclin B1-Cdk1 first appears on centrosomes in prophase. Nat Cell Biol (2003) 4.31
Loss of human Greatwall results in G2 arrest and multiple mitotic defects due to deregulation of the cyclin B-Cdc2/PP2A balance. Proc Natl Acad Sci U S A (2010) 4.07
Distinct stem cell populations regenerate the follicle and interfollicular epidermis. Dev Cell (2005) 3.98
The substrate of Greatwall kinase, Arpp19, controls mitosis by inhibiting protein phosphatase 2A. Science (2010) 3.27
Epidermal stem cells arise from the hair follicle after wounding. FASEB J (2007) 2.81
beta-catenin activity in the dermal papilla regulates morphogenesis and regeneration of hair. Dev Cell (2010) 2.60
Kinetochore localization of spindle checkpoint proteins: who controls whom? Mol Biol Cell (2004) 2.50
E4F1 is an atypical ubiquitin ligase that modulates p53 effector functions independently of degradation. Cell (2006) 2.50
Greatwall maintains mitosis through regulation of PP2A. EMBO J (2009) 2.22
Early mitotic degradation of Nek2A depends on Cdc20-independent interaction with the APC/C. Nat Cell Biol (2006) 2.20
APC/C Cdh1 targets aurora kinase to control reorganization of the mitotic spindle at anaphase. Curr Biol (2008) 2.18
Spastin couples microtubule severing to membrane traffic in completion of cytokinesis and secretion. Traffic (2008) 2.16
The anaphase-promoting complex: a key factor in the regulation of cell cycle. Oncogene (2005) 1.85
A non-proteolytic role for ubiquitin in Tat-mediated transactivation of the HIV-1 promoter. Nat Cell Biol (2003) 1.82
Intrinsic ubiquitination activity of PCAF controls the stability of the oncoprotein Hdm2. Nat Cell Biol (2007) 1.70
Par-1 regulates stability of the posterior determinant Oskar by phosphorylation. Nat Cell Biol (2002) 1.70
The serine protease Corin is a novel modifier of the Agouti pathway. Development (2007) 1.69
The proteasome regulates HIV-1 transcription by both proteolytic and nonproteolytic mechanisms. Mol Cell (2007) 1.56
APC/Fizzy-Related targets Aurora-A kinase for proteolysis. EMBO Rep (2002) 1.45
Greatwall is essential to prevent mitotic collapse after nuclear envelope breakdown in mammals. Proc Natl Acad Sci U S A (2013) 1.33
A capsid-encoded PPxY-motif facilitates adenovirus entry. PLoS Pathog (2010) 1.29
Alterations of anaphase-promoting complex genes in human colon cancer cells. Oncogene (2003) 1.25
Characterization of the mechanisms controlling Greatwall activity. Mol Cell Biol (2011) 1.25
Characterization and expression of mammalian cyclin b3, a prepachytene meiotic cyclin. J Biol Chem (2002) 1.22
Beta-catenin activity in the dermal papilla of the hair follicle regulates pigment-type switching. Proc Natl Acad Sci U S A (2010) 1.19
Uncoupling anaphase-promoting complex/cyclosome activity from spindle assembly checkpoint control by deregulating polo-like kinase 1. Mol Cell Biol (2005) 1.16
Xkid is degraded in a D-box, KEN-box, and A-box-independent pathway. Mol Cell Biol (2003) 1.16
Meiotic regulation of the CDK activator RINGO/Speedy by ubiquitin-proteasome-mediated processing and degradation. Nat Cell Biol (2006) 1.12
Proteolysis: anytime, any place, anywhere? Nat Cell Biol (2005) 1.12
The Aurora-A/TPX2 complex: a novel oncogenic holoenzyme? Biochim Biophys Acta (2010) 1.10
The D-Box-activating domain (DAD) is a new proteolysis signal that stimulates the silent D-Box sequence of Aurora-A. EMBO Rep (2002) 1.09
Control of Aurora-A stability through interaction with TPX2. J Cell Sci (2010) 1.09
Pin1 stabilizes Emi1 during G2 phase by preventing its association with SCF(betatrcp). EMBO Rep (2006) 1.07
CDK-dependent potentiation of MPS1 kinase activity is essential to the mitotic checkpoint. Curr Biol (2012) 1.06
Lessons from interconnected ubiquitylation and acetylation of p53: think metastable networks. Biochem Soc Trans (2010) 1.02
Proteasome inhibitors: Dozens of molecules and still counting. Biochimie (2010) 1.01
Identification and initial characterization of three novel cyclin-related proteins of the human malaria parasite Plasmodium falciparum. J Biol Chem (2003) 1.01
The ectodysplasin pathway in feather tract development. Development (2005) 0.99
H19 antisense RNA can up-regulate Igf2 transcription by activation of a novel promoter in mouse myoblasts. PLoS One (2012) 0.98
Differential regulation of Cdc2 and Aurora-A in Xenopus oocytes: a crucial role of phosphatase 2A. J Cell Sci (2005) 0.98
Quantitative live imaging of endogenous DNA replication in mammalian cells. PLoS One (2012) 0.96
Involvement of Aurora A kinase during meiosis I-II transition in Xenopus oocytes. J Biol Chem (2002) 0.95
Regulation of bovine papillomavirus replicative helicase e1 by the ubiquitin-proteasome pathway. J Virol (2002) 0.94
MyoD undergoes a distinct G2/M-specific regulation in muscle cells. Exp Cell Res (2006) 0.94
Transcription factor E4F1 is essential for epidermal stem cell maintenance and skin homeostasis. Proc Natl Acad Sci U S A (2010) 0.92
Substrate targeting by the ubiquitin-proteasome system in mitosis. Semin Cell Dev Biol (2012) 0.91
Control of p53 multimerization by Ubc13 is JNK-regulated. Proc Natl Acad Sci U S A (2009) 0.91
A novel role for PA28gamma-proteasome in nuclear speckle organization and SR protein trafficking. Mol Biol Cell (2008) 0.91
Budding yeast greatwall and endosulfines control activity and spatial regulation of PP2A(Cdc55) for timely mitotic progression. PLoS Genet (2013) 0.91
Cdc2-cyclin B triggers H3 kinase activation of Aurora-A in Xenopus oocytes. J Biol Chem (2003) 0.90
Degradation of newly synthesized polypeptides by ribosome-associated RACK1/c-Jun N-terminal kinase/eukaryotic elongation factor 1A2 complex. Mol Cell Biol (2013) 0.90
Ubiquitin-recognition protein Ufd1 couples the endoplasmic reticulum (ER) stress response to cell cycle control. Proc Natl Acad Sci U S A (2011) 0.89
Spatiotemporal organization of Aurora-B by APC/CCdh1 after mitosis coordinates cell spreading through FHOD1. J Cell Sci (2013) 0.89
Autophosphorylation properties of inactive and active JNK2. Cell Cycle (2007) 0.89
Histone H3 phosphorylation during Xenopus oocyte maturation: regulation by the MAP kinase/p90Rsk pathway and uncoupling from DNA condensation. FEBS Lett (2002) 0.88
βTrCP-dependent degradation of CDC25B phosphatase at the metaphase-anaphase transition is a pre-requisite for correct mitotic exit. Cell Cycle (2010) 0.87
Ubiquitination site preferences in anaphase promoting complex/cyclosome (APC/C) substrates. Open Biol (2013) 0.87
Bovine papillomavirus replicative helicase E1 is a target of the ubiquitin ligase APC. J Virol (2004) 0.87
Affinity purification of protein complexes from Drosophila embryos in cell cycle studies. Methods Mol Biol (2014) 0.87
E4F1 deficiency results in oxidative stress-mediated cell death of leukemic cells. J Exp Med (2011) 0.85
Regulation of the 26S proteasome activities by peptides mimicking cleavage products. Biochem Biophys Res Commun (2002) 0.83
Fate of implanted syngenic muscle precursor cells in striated urethral sphincter of female rats: perspectives for treatment of urinary incontinence. Urology (2004) 0.82
Intrasphincteric injections of autologous muscular cells in women with refractory stress urinary incontinence: a prospective study. Int Urogynecol J (2010) 0.82
The master Greatwall kinase, a critical regulator of mitosis and meiosis. Int J Dev Biol (2016) 0.80
XCdh1 is involved in progesterone-induced oocyte maturation. Dev Biol (2004) 0.80
Dose effect relationship between the number of normal progenitor muscle cells grafted in mdx mouse skeletal striated muscle and the number of dystrophin-positive fibres. Neurosci Lett (2003) 0.79
SUMO2/3 modification of cyclin E contributes to the control of replication origin firing. Nat Commun (2013) 0.78
Roles and potential therapeutic targets of the ubiquitin proteasome system in muscle wasting. BMC Biochem (2007) 0.78
Interaction between the antiapoptotic protein Nr-13 and cytochrome c. Antagonistic effect of the BH3 domain of Bax. Biochemistry (2002) 0.78
The anaphase-promoting complex or cyclosome supports cell survival in response to endoplasmic reticulum stress. PLoS One (2012) 0.77
HIV-1, ubiquitin and ubiquitin-like proteins: the dialectic interactions of a virus with a sophisticated network of post-translational modifications. Biol Cell (2012) 0.77
High yield bacterial expression and purification of active recombinant PA28alphabeta complex. Protein Expr Purif (2008) 0.77
Use of a serum-free medium to produce in vitro Neospora caninum and Toxoplasma gondii tachyzoites on Vero cells. Vet Res (2002) 0.77
Exploring meiotic division in Cargèse. Meeting on meiotic divisions and checkpoints. EMBO Rep (2005) 0.76
UnCHKed DNA replication: A stressful matter. Cell Cycle (2012) 0.75
Kizuna is a novel mitotic substrate for CDC25B phosphatase. Cell Cycle (2014) 0.75
[Mitosis under control]. Med Sci (Paris) (2003) 0.75
Ubiquitin-mediated protein degradation in Xenopus egg extracts. Methods Mol Biol (2006) 0.75
[Death-tag]. Med Sci (Paris) (2004) 0.75
Noncultured, autologous, skeletal muscle cells can successfully engraft into ovine myocardium. Circulation (2003) 0.75
Long-term follow-up after regenerative therapy of the urethral sphincter for female stress urinary incontinence. Eur Urol (2013) 0.75
[Greatwall, a new guardian of mitosis]. Med Sci (Paris) (2011) 0.75